From *:Andrew Chapman of Merchant Group, a major shareholder in both companies, says the merger will create a company with a $13.7m warchest and cost savings of at least $1m a year.
“It’s a great time to do a deal likethis,” he said, as companies across the ASX struggle for money and are lookingfor ways to save cash.
The two companies will use that cash tolook for other companies to buy or to licence new medical technologies.
Ann: Bard1 and Sienna Cancer Diagnostics announce merger, page-94
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
-0.025(4.76%) |
Mkt cap ! $55.76M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 53.0¢ | 50.0¢ | $160.3K | 315.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40373 | 49.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 9050 | 1 |
View Market Depth
| Last trade - 15.58pm 13/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |